Evidence map›Paper›PMID 26934704›Full record

ArticlePLoS biology2016

Transforming Global Health by Improving the Science of Scale-Up.

Margaret E Kruk, Gavin Yamey, Sonia Y Angell, Alix Beith, Daniel Cotlear, Frederico Guanais, Lisa Jacobs, Helen Saxenian, Cesar Victora, Eric Goosby

Open access · goldAbstract read
In one paragraph

Article in PLoS biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 3 pooled it
17.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 3 syntheses or guidelines pooled it, 80 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Development and Application of the Scale-Up Reflection Guide (SRG).International journal of environmental research and public health · 2023
    Article
  11. Article
  12. Article
  13. Article
  14. Seizing the moment to rethink health systems.The Lancet. Global health · 2021
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 2 countries.

Margaret E KrukDepartment of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America.
Gavin YameyEvidence to Policy Initiative, Global Health Group, University of California San Francisco, San Francisco, California, United States of America.
Sonia Y AngellNew York City Department of Health and Mental Hygiene, Long Island City, New York, United States of America.
Alix BeithIndependent global health consultant, Arlington, Virginia, United States of America.
Daniel CotlearHealth, Nutrition and Population, World Bank Group, Washington, District of Columbia, United States of America.
Frederico GuanaisSocial Protection and Health Division, Inter-American Development Bank, Lima, Peru.
Lisa JacobsIndependent global health consultant, San Francisco, California, United States of America.
Helen SaxenianResults for Development, Washington, District of Columbia, United States of America.
Cesar VictoraInternational Center for Equity in Health, Federal University of Pelotas, Pelotas, Brazil.
Eric GoosbyGlobal Health Delivery and Diplomacy, Global Health Sciences, University of California San Francisco, San Francisco, California, United States of America.
University of California, San Francisco · USHarvard Global Health Institute · USInter-American Development Bank · USNew York City Department of Health and Mental Hygiene · USResults for Development Institute · USUniversidade Federal de Pelotas · BRWorld Bank Group · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In its report Global Health 2035, the Commission on Investing in Health proposed that health investments can reduce mortality in nearly all low- and middle-income countries to very low levels, thereby averting 10 million deaths per year from 2035 onward. Many of these gains could be achieved through scale-up of existing technologies and health services. A key instrument to close this gap is policy and implementation research (PIR) that aims to produce generalizable evidence on what works to implement successful interventions at scale. Rigorously designed PIR promotes global learning and local accountability. Much greater national and global investments in PIR capacity will be required to enable the scaling of effective approaches and to prevent the recycling of failed ideas. Sample questions for the PIR research agenda include how to close the gap in the delivery of essential services to the poor, which population interventions for non-communicable diseases are most applicable in different contexts, and how to engage non-state actors in equitable provision of health services in the context of universal health coverage.

Indexed as

Global HealthDelivery of Health CareHealth Policy

Identifiers

PMID26934704
PMCPMC4775018
OpenAlexW2291345369

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.